Anika Therapeutics | ANIK - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Abbott USD 178.41B 39.46B 2026-03
Agenus USD 107M 16M 2025-12
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 8.78B 236M 2026-03
Enanta Pharmaceuticals USD 122M 98M 2024-12
Halozyme Therapeutics USD 7.66B 257M 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 35.3B 1.82B 2026-03
Integra LifeSciences USD 733M 234M 2026-03
J&J USD 579.15B 78.91B 2026-03
Karyopharm Therapeutics USD 1.05B 912M 2026-06
Ligand Pharmaceuticals USD 3.98B 241M 2026-03
Merit Medical Systems USD 4.11B 1.11B 2026-03
Sanofi EUR 100.27B 605.48M 2026-03
Smith & Nephew USD 3.45B 9.87B 2026-06
Stryker USD 125.85B 8.57B 2026-03
Veracyte USD 2.57B 758M 2026-03
Xencor USD 893M 200M 2026-03
Zimmer Biomet Holdings USD 17.5B 321M 2026-03